Changes in number and biological function of endothelial progenitor cells in hypertension disorder complicating pregnancy

Abstract

To examine the changes in number and function of endothelial progenitor cells (EPCs) from peripheral blood (PB) in hypertension disorder complicating pregnancy (HDCP), 20 women with HDCP and 20 normal pregnant women at the third trimester were studied. Mononuclear cells (MNCs) from PB were isolated by Ficoll density gradient centrifugation. EPCs were identified by positive expression of both CD34 and CD133 under fluorescence microscope and positive expression of factor VIII as shown by immunocytochemistry. The number of EPCs was flow-cytometrically determined. Proliferation and migration of EPCs were measured by MTT assay and modified Boyden chamber assay, respectively. The adhesion activity of EPCs was detected by counting the number of the adherent cells. The results showed that, compared with normal pregnant women, the number of EPCs was significantly reduced in HDCP (4.29%±1.21% vs 15.32%±2.00%, P<0.01), the functional activity of EPCs in HDCP, such as proliferation (13.45%±1.68% vs 18.45%±1.67%), migration (37.25±7.28 cells/field vs 67.10±9.55 cells/field) and adhesion activity (20.65±5.19 cells/field vs 34.40±6.72 cells/filed) was impaired (P<0.01). It is concluded that the number and function of EPCs are significantly decreased in HDCP.

Keywords

hypertension disorder complicating pregnancy / endothelial progenitor cells / biological function

References

[1] HristovM., ErlW., WeberP. C., et al.. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol, 2003, 23: 1185-1189

[2] WernerN., JunkS., LaufsA., et al.. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res, 2003, 93: e17-e24

[3] YoonY. S., LeeN., ScadovaH., et al.. Myocardial regeneration with bone marrow derived stem cells. Biol Cell, 2005, 97: 253-263

[4] WernerN., PrillerJ., LaufsU., et al.. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol, 2002, 22: 1567-1572

[5] GulatiR., JevremovicD., PetersonT. E., et al.. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation, 2003, 108: 1520-1526

[6] VasaM., FichtlschererS., AicherA., et al.. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001, 89: E1-E7

[7] PowellT.M., PaulJ.D., HillJ.M., et al.. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol, 2005, 25: 296-301

[8] LeJ., XieX., FengY. J., et al.Obstetrics and Gynecology (Chinese), 2005BeijingPeople’s Medical Publishing House97-104

[9] KalkaC., MasudaH., TakahashiT., et al.. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3422-3427

[10] RohdeE., MalischnikC., ThalerD.. Blood monocytes mimic endothelial progenitor cells. Stem cells, 2006, 24: 357-367

[11] LyallF., GreerI. A.. The vascular endothelium in normal pregnancy and pre-eclampsia. Rev Reprod, 1996, 1: 107-116

[12] HillJ. M., ZalosG., HalcoxJ. P., et al.. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348: 593-600

[13] AsaharaT., MuroharaT., SullivanA., et al.. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997, 275: 964-967

[14] GehlingU. M., ErgünS., SchumacherU., et al.. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood, 2000, 95: 3106-3112

[15] PeichevM., NaiyerA. J., PereiraD., et al.. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial pre-cursors. Blood, 2000, 95: 952-958

[16] QuiriciN., SoliqoD., CanevaL., et al.. Differentiation and expansion of endothelial cells from human bone marrow CD133 (+) cells. Br J Haematol, 2001, 115: 186-194

[17] WalterD. H., RittigK., BahlmannF. H., et al.. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation, 2002, 105(25): 3017-3024

[18] AsaharaT., KawamotoA.. Endothelial progenitor cells for postnatal vasculogenesis. Am J physiol cell physiol, 2004, 28: C572-C579

[19] Schmidt-LuckeC., RössigL., FichtlschererS., et al.. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation, 2005, 22: 2981-2987

[20] ImanisihiT., MoriwakiC., HanoT., et al.. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens, 2005, 23: 1831-1837